2025-01-29 10-52-06

Content

Daily intraperitoneal injections of 2.5 mg/kg Urolithin A in mice reduce the pain-related behavioral deficits from chronic Sciatic Nerve constriction compared to mice not administered urolithin A when injections begin immediately after constriction surgery

Source Content9
wangUrolithinAlleviatesNeuropathic2023 - Materials and methods (mechanical withdrawal threshold (MWT) and thermal withdrawal latency (TWL) testing)
wangUrolithinAlleviatesNeuropathic2023 - Materials and methods (gait analysis)
wangUrolithinAlleviatesNeuropathic2023 - Materials and methods (animals)
wangUrolithinAlleviatesNeuropathic2023 - Materials and methods (administration of drugs)
wangUrolithinAlleviatesNeuropathic2023 - Materials and methods (CCI model preparation)
wangUrolithinAlleviatesNeuropathic2023 - Figure 3E
wangUrolithinAlleviatesNeuropathic2023 - Figure 3D
wangUrolithinAlleviatesNeuropathic2023 - Figure 3B
wangUrolithinAlleviatesNeuropathic2023 - Figure 3C

Original Sources1	Citations
wangUrolithinAlleviatesNeuropathic2023	Wang, Chenyi, Zizhu Wang, Shiyu Xue, Yutong Zhu, Jiahao Jin, Qiuyu Ren, and Xiaodong Shi. “Urolithin A Alleviates Neuropathic Pain and Activates Mitophagy.” Molecular Pain 19 (July 28, 2023): 17448069231190815. https://doi.org/10.1177/17448069231190815.